Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Digestive System Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients George Albert Fisher M.D. Ph.D.
 Gastrointestinal Stromal Tumors
Phase I Vandetanib plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer Branimir I Sikic
 Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
A Phase II Study of GSK1363089 (Formerly XL880) for Metastatic Gastric Cancer James M Ford
 Stomach Cancer
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project Dr Andrew Quon
 Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer Dr Andrew Shelton
 Rectal Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma George Albert Fisher M.D. Ph.D.
 Stomach Cancer
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Amreen Husain
 Ovarian Cancer
Fallopian Tube Neoplasms
Peritoneal Neoplasms

Device Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Impact of C-arm CT in patients with HCC undergoing TACE: Optimal Imaging Guidance Dr. Rebecca Fahrig
Nishita N. Kothary
 Carcinoma, Hepatocellular

Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors Kate R Lorig
 Breast Cancer
Prostatic Neoplasms
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Blood Cancer
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma James M Ford
 Digestive System Neoplasms
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors Paul J Keall
Amit Sawant
 Pancreatic Cancer
Liver Cancer
Lung Cancer
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer Mark Lane Welton
 Rectal Cancer
Molecular Genetic and Pathological Studies of Anal Tumors Mark Lane Welton
 Rectal Cancer
Anal Cancer
Colonic Neoplasms
Colon Cancer
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT Mark Lane Welton
 Anal Cancer
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample Irene L. Wapnir
 Breast Cancer
Salivary Gland Neoplasms
Stomach Cancer
Thyroid Cancer
Permission to Collect Blood over Time for Research Haruka Itakura
 Gastrointestinal Neoplasms
Pancreatic Cancer
Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors George Albert Fisher M.D. Ph.D.
Russell Pachynski
 Head and Neck Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Colonic Neoplasms
Lung Cancer
Colon Cancer

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
(Completed) 		Albert Koong
 Pancreatic Cancer
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
(Completed) 		George Albert Fisher M.D. Ph.D.
Edgar G Engleman
 Pancreatic Cancer
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
(Suspended) 		Harlan Pinto
 Colonic Neoplasms
Colon Cancer
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
(Terminated) 		Albert Koong
 Rectal Cancer
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
(Completed) 		Albert Koong
 Pancreatic Cancer
Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer
(No longer recruiting) 		George Albert Fisher M.D. Ph.D.
 Pancreatic Cancer
Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
(Completed) 		Albert Koong
 Pancreatic Cancer
Microarray Analysis of Gene Expression in Liver Tumors
(Completed) 		Samuel So
 Liver Cancer
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
(Completed) 		Albert Koong
 Cholangiocarcinoma
Liver Cancer
Adenocarcinoma
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
(No longer recruiting) 		Daniel T Chang
 Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
Safety Study of Cetuximab in combination with Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
(Completed) 		George Albert Fisher M.D. Ph.D.
Branimir I Sikic
 Rectal Cancer
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
(Terminated) 		Samuel So
 Carcinoma, Hepatocellular


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: